Vibativ
Product Images NDC 52118-001

3 FDA label images from Theravance, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vibativ (NDC 52118-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Theravance, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Vib02 0012 01)

Figure 1 (Vib02 0012 01)
Chemical structure diagram of Telavancin hydrochloride, the active ingredient in Vibativ by Theravance, Inc. The structure shows the molecular bonds and arrangement of atoms with a note indicating where x HCl ranges from 1 to 3.*
FDA Label Image

Package Label – Principal Display Panel – 250 mg/vial Unit Carton (Vib02 0016 02)

Package Label – Principal Display Panel – 250 mg/vial Unit Carton (Vib02 0016 02)
Packaging label for Vibativ 250 mg/vial (telavancin) for injection, a sterile, lyophilized, preservative-free intravenous infusion. The box includes dosing and storage instructions, stating it is a single-use vial to be stored refrigerated at 2° to 8°C. Manufactured by Theravance, Inc., South San Francisco, CA, the label also has reconstitution directions and a medication guide reminder.*
FDA Label Image

Package Label – Principal Display Panel – 750 mg/vial Unit Carton (Vib02 0016 03)

Package Label – Principal Display Panel – 750 mg/vial Unit Carton (Vib02 0016 03)
Packaging label for Vibativ (telavancin) for injection, 750 mg per vial, manufactured by Theravance, Inc. The label includes preparation instructions, storage conditions, and a note to dispense with the enclosed Medication Guide. It specifies that the vial is single use and preservative-free, with ingredients including telavancin hydrochloride equivalent to 750 mg telavancin, hydroxypropyl-beta-dextran, and mannitol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.